anlak storytelling
All kinds
Document kinds
Loading document kinds...

Primary corpus lens for browsing and insights. Selection lives in the URL.

All formats
Orientation
Loading formats...

Landscape, portrait, square, or unknown document geometry.

Unlock
slides · global inventory

Image

Component collection for the active corpus filters, with each row opening the slide detail view.

Search Insights JSON Unlock
Matching slides 119,566
Current window 67,081-67,110
Pages 3,986
Rows per page 30
Component: Imageclear collectionreset all
18 30 60

Component

67,081-67,110 of 119,566

filter-aware
115
Includes a direct quote from a 'solid-state battery researcher' highlighting the non-standard nature of the data reporting.QuantumScape (QS) · Scorpion Capital
Activist deck Short seller Beat · Critique of Quantumscape's claims and technology1 hit
117
Includes a pull-quote from a battery researcher and a visual callout of a specific chart axis.QuantumScape (QS) · Scorpion Capital
Activist deck Short seller Beat · Critique of Quantumscape's claims and technology1 hit
118
Includes a specific reference to a previous slide (#19) and highlights expert quotes.QuantumScape (QS) · Scorpion Capital
Activist deck Short seller Beat · Critique of Quantumscape's claims and technology1 hit
120
Uses a metaphor of 'one-story shacks' vs '100 story skyscrapers' to illustrate the technical gap.QuantumScape (QS) · Scorpion Capital
Activist deck Short seller Beat · Critique of Quantumscape's claims and technology1 hit
124
The slide uses a screenshot of a video interview to highlight a perceived contradiction in the CEO's messaging.QuantumScape (QS) · Scorpion Capital
Activist deck Short seller Beat · Critique of Quantumscape's claims and technology1 hit
144
Uses a video screenshot and a direct quote to establish authority and cast doubt on a competitor's feasibility.QuantumScape (QS) · Scorpion Capital
Activist deck Short seller Beat · Critique of Quantumscape's claims and technology1 hit
151
Uses expert testimony and external media citations to undermine the company's technical viability.QuantumScape (QS) · Scorpion Capital
Activist deck Short seller Loop · Cost Of Inaction1 hit
153
Includes a direct quote from a former employee and a screenshot from a company presentation to illustrate the scaling gap.QuantumScape (QS) · Scorpion Capital
Activist deck Short seller Loop · Cost Of Inaction1 hit
161
The slide uses a historical precedent to frame current battery company claims as part of a recurring pattern of fraud.QuantumScape (QS) · Scorpion Capital
Activist deck Short seller Loop · Cost Of Inaction1 hit
162
Uses a screenshot of a Medium article to provide external validation for the claim of systemic fraud.QuantumScape (QS) · Scorpion Capital
Activist deck Short seller Loop · Cost Of Inaction1 hit
163
Uses a specific analogy to biotech (Phase 3 success vs. rodent data) to frame the technical limitation as a deceptive practice.QuantumScape (QS) · Scorpion Capital
Activist deck Short seller Loop · Cost Of Inaction1 hit
168
Includes a screenshot of a tweet by Vinod Khosla and a quote from Barron's to illustrate the 'celebrity endorsement' and hype.QuantumScape (QS) · Scorpion Capital
Activist deck Short seller Loop · Cost Of Inaction1 hit
170
Uses a 'villain' narrative technique to undermine investor credibility.QuantumScape (QS) · Scorpion Capital
Activist deck Short seller Loop · Cost Of Inaction1 hit
172
Uses a quote from Steve LeVine (Quartz) and a photo of Obama with Sakti3 founder to establish credibility and highlight the 'hype' narrative.QuantumScape (QS) · Scorpion Capital
Activist deck Short seller Loop · Cost Of Inaction1 hit
179
Uses SEC filing excerpts and a Notice of Effectiveness screenshot as evidence of insider dumping.QuantumScape (QS) · Scorpion Capital
Activist deck Short seller Loop · Cost Of Inaction1 hit
07
The slide uses a screenshot of a Facebook post to undermine the clinical trial results of the drug VYKAT.Soleno Therapeutics (SLNO) · Scorpion Capital
Activist deck Short seller 1 hit
12
Uses social media screenshots as primary evidence to build a case against the drug's safety profile.Soleno Therapeutics (SLNO) · Scorpion Capital
Activist deck Short seller 1 hit
15
Uses a screenshot of a Facebook group post as primary evidence to support the claim of medical danger.Soleno Therapeutics (SLNO) · Scorpion Capital
Activist deck Short seller 1 hit
16
Uses direct quotes from Facebook posts to highlight patient safety concerns.Soleno Therapeutics (SLNO) · Scorpion Capital
Activist deck Short seller 1 hit
17
The slide highlights a discrepancy between the FDA label's explicit warnings about DKA and the company's omission of this risk in their phase 3 and open-label manuscripts.Soleno Therapeutics (SLNO) · Scorpion Capital
Activist deck Short seller 1 hit
25
Uses emotional appeal and visual evidence to highlight the difficulty of diagnosing edema in PWS patients.Soleno Therapeutics (SLNO) · Scorpion Capital
Activist deck Short seller 1 hit
26
The slide uses anecdotal evidence from online discussion groups to highlight patient safety concerns.Soleno Therapeutics (SLNO) · Scorpion Capital
Activist deck Short seller 1 hit
27
The slide uses screenshots of Facebook group discussions to provide anecdotal evidence of adverse drug reactions.Soleno Therapeutics (SLNO) · Scorpion Capital
Activist deck Short seller 1 hit
28
The slide uses screenshots of Facebook group posts as primary evidence of adverse drug reactions.Soleno Therapeutics (SLNO) · Scorpion Capital
Activist deck Short seller 1 hit
29
Uses patient testimonials as primary evidence to challenge the safety profile of the drug.Soleno Therapeutics (SLNO) · Scorpion Capital
Activist deck Short seller 1 hit
30
The slide uses direct quotes from Facebook groups to undermine the product's safety/efficacy narrative.Soleno Therapeutics (SLNO) · Scorpion Capital
Activist deck Short seller 1 hit
31
The slide uses direct quotes from a Facebook discussion group to highlight the patient/caregiver pain point of symptom detection.Soleno Therapeutics (SLNO) · Scorpion Capital
Activist deck Short seller 1 hit
32
The slide uses social media engagement (comment counts) as a proxy for negative sentiment and community concern.Soleno Therapeutics (SLNO) · Scorpion Capital
Activist deck Short seller 1 hit
34
The slide uses a screenshot of a Soleno clinical trial flow diagram to highlight patient drop-off.Soleno Therapeutics (SLNO) · Scorpion Capital
Activist deck Short seller 1 hit
37
The slide uses a 'villain' narrative by framing patient advocacy groups as manipulators of the regulatory process.Soleno Therapeutics (SLNO) · Scorpion Capital
Activist deck Short seller 1 hit